These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3521615)

  • 21. Prostacyclin (PGI2) inhibits the formation of platelet thrombi induced by adenosine diphosphate (ADP) in vivo [proceedings].
    Higgs GA; Moncada S; Vane JR
    Br J Pharmacol; 1977 Sep; 61(1):137P. PubMed ID: 334306
    [No Abstract]   [Full Text] [Related]  

  • 22. Marked enhancement in antithrombotic activity of isocarbacyclin following its incorporation into lipid microspheres.
    Mizushima Y; Igarashi R; Hoshi K; Sim AK; Cleland ME; Hayashi H; Goto J
    Prostaglandins; 1987 Feb; 33(2):161-8. PubMed ID: 3296005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antioxidant activity of nitro derivative of aspirin against ischemia-reperfusion in hamster cheek pouch microcirculation.
    Bertuglia S; Giusti A; Del Soldato P
    Am J Physiol Gastrointest Liver Physiol; 2004 Mar; 286(3):G437-43. PubMed ID: 14563672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostacyclin (PGI2) inhibits the formation of platelet thrombi in arterioles and venules of the hamster cheek pouch. 1977.
    Higgs EA; Higgs GA; Moncada S; Vane JR
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):439-43; discussion 437-8. PubMed ID: 9142422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC; Crain EJ; Watson CA; Zaspel AM; Wright MR; Lam PY; Pinto DJ; Wexler RR; Knabb RM
    J Pharmacol Exp Ther; 2002 Dec; 303(3):993-1000. PubMed ID: 12438519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antithrombotic activity of viquidil, a cerebral vasodilator.
    Sim AK; Uzan A
    Arzneimittelforschung; 1979; 29(3):508-11. PubMed ID: 582736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ticlopidine and platelet function.
    Lecompte T; Lecrubier C; Potevin F; Samama M
    Thromb Haemost; 1986 Jun; 55(3):437-8. PubMed ID: 3529484
    [No Abstract]   [Full Text] [Related]  

  • 28. Platelet aggregometry and receptor binding to predict the magnitude of antithrombotic and bleeding time effects of clopidogrel in rabbits.
    Wong PC; Crain EJ; Watson CA; Jiang X; Hua J; Bostwick JS; Ogletree ML; Schumacher WA; Rehfuss R
    J Cardiovasc Pharmacol; 2007 May; 49(5):316-24. PubMed ID: 17513951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of oral administration of different doses of purified micronized flavonoid fraction on microvascular reactivity after ischaemia/reperfusion in the hamster cheek pouch.
    Bouskela E; Cyrino FZ; Lerond L
    Br J Pharmacol; 1997 Dec; 122(8):1611-6. PubMed ID: 9422805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet aggregation in arterioles of the hamster cheek pouch and in heart transplants: its tissue-dependent influencibility by acetylsalicylic acid and nafazatrom.
    Herrmann KS; Seuter F
    Haemostasis; 1984; 14(3):281-7. PubMed ID: 6381254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular and antithrombotic effects of ZK 96 480, a novel metabolically stable carbacyclin derivative with oral activity.
    Stürzebecher CS; Loge O; Schröder G; Müller B; Witt W
    Prog Clin Biol Res; 1987; 242():425-31. PubMed ID: 3313417
    [No Abstract]   [Full Text] [Related]  

  • 33. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diameter of arterial microvessels trapping 8--10 micron, 15 micron and 25 micron microspheres as determined by vital microscopy of the hamster cheek pouch.
    Dickhoner WH; Bradley BR; Harell GS
    Invest Radiol; 1978; 13(4):313-7. PubMed ID: 689824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of prostacyclin on platelet aggregation as studied with "filter-loop" technique in the flowing blood of the dog.
    Imai S; Matsubara I
    Artery; 1980; 8(1):63-72. PubMed ID: 7000043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-Keto-prostaglandin E1 is more potent than prostaglandin I2 as a renal vasodilator and renin secretagogue.
    Jackson EK; Herzer WA; Zimmerman JB; Branch RA; Oates JA; Gerkens JF
    J Pharmacol Exp Ther; 1981 Jan; 216(1):24-7. PubMed ID: 7005428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longchain n-3 polyunsaturated fatty acids and microvascular reactivity: observation in the hamster cheek pouch.
    Conde CM; Cyrino FZ; Bottino DA; Gardette J; Bouskela E
    Microvasc Res; 2007 May; 73(3):237-47. PubMed ID: 17196224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antithrombotic effects of the prostacyclin analogue naxaprostene after oral and intraduodenal application in rabbit carotid artery thrombosis.
    Schneider J
    Agents Actions Suppl; 1992; 37():176-82. PubMed ID: 1632291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The vascular protection of ditazole and its effect on arachidonic acid metabolism.
    Sim AK; McCraw AP; Caprino L; Antonetti F; Martelli F; Morelli L
    Thromb Res; 1983 Dec; 32(5):479-93. PubMed ID: 6140774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dipyridamole--evaluation of an established antithrombotic drug in view of modern concepts of blood cell-vessel wall interactions.
    Eisert WG; Müller TH
    Thromb Res Suppl; 1990; 12():65-72. PubMed ID: 2082490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.